M-tron Industries, Inc. (MPTI) is a U.S.-listed stock, not an ETF, and it has only limited sell-side coverage. Two current, clearly attributed targets form the basis of the central figure. Sidoti analyst Anja Soderstrom raised the firm's price target to $90 from $87 in mid-August 2026, keeping a Hold rating, and justified the target by applying a 35x multiple to a 2027 EPS estimate of $2.54. Freedom Broker's Sergey Glinyanov downgraded the stock to Hold from Buy in May 2026 while lifting the target to $81 from $78.
The arithmetic mean of these two targets is $85.50, rounded to a clean $85. The range is narrow — $81 to $90 — but because only two firms cover the name, the "analyst consensus" is best read as a neutral, low-conviction stance rather than a broad market view. Neither firm currently carries a Buy rating, which is notable: the targets imply meaningful upside, yet the formal recommendations remain cautious. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares of M-tron Industries have traded in a wide range, from a 52-week low of $43.55 to a high of $104.85, and recently closed near $64 after a sharp pullback from that peak. Reaching $85 would require an increase of about 32% from the recent price, which qualifies as a substantial move rather than a modest one.
The company designs and manufactures highly engineered frequency and spectrum control products — crystal oscillators, filters, and related timing devices — used in aerospace, defense, space, and avionics applications. Second-quarter 2026 results showed record revenue of about $15.1 million, up roughly 14% year over year, with adjusted EBITDA rising around 40%. Management has emphasized record backlog growth and a strong pipeline, which provides some visibility. At the same time, the shares carry a trailing P/E ratio in the mid-20s on roughly $58 million of trailing revenue, reflecting a valuation premium typical of a small, defense-exposed growth name.
Several factors could underpin a recovery toward $85. A rising backlog and continued defense procurement — across missile, radar, and satellite end markets — could sustain double-digit revenue growth. The balance sheet is a genuine strength: the company holds roughly $97 million in cash with negligible debt, giving it flexibility for organic investment or inorganic acquisitions that analysts note are not yet in their models. Sidoti's $90 target is grounded in projected 2027 EPS of $2.54, implying that if earnings compound as expected, the multiple-based valuation could support a higher share price. Any re-acceleration in margins or a return of investor enthusiasm for defense suppliers could also help narrow the gap between the current price and the prior high.
The principal obstacles are valuation, execution, and volatility. The stock trades at a premium to peers and to its own book value, and gross margins have faced pressure even as revenue grows. Quarterly results have at times missed consensus expectations, and Freedom Broker's downgrade to Hold in May 2026 signaled that near-term fundamentals had not kept pace with the earlier rally. As a micro-cap with a float of only a few million shares, MPTI is prone to sharp swings unrelated to fundamentals. If backlog conversion slows, margins compress further, or defense demand softens, the shares could remain well below $85, or the analysts could trim their targets.
The recent price sits below both the 50-day moving average (around $71) and the 200-day moving average (around $75), reflecting a downtrend from the 52-week high. Those averages, along with the psychological $70–$75 zone, form a near-term resistance area that the stock would likely need to reclaim before testing the $85–$90 target zone. On the downside, recent lows near $57–$60 represent the first meaningful support, with the 52-week low of $43.55 below that. The $104.85 prior high shows how quickly the stock can re-rate when sentiment turns, but also how far it has already fallen.
Analyst price targets generally reflect a roughly 12-month research horizon, and Sidoti's target explicitly anchors on 2027 EPS, implying a slightly longer view. Investors should watch the next earnings report and guidance, order and backlog disclosures, gross-margin trends, and any analyst target or rating revisions. Defense budget developments, interest-rate expectations, and overall risk appetite for small-cap growth names will also matter. Because coverage is so thin, a single analyst action can move both the perceived consensus and the stock itself.
The $85 central target — the mean of the two verified analyst targets of $81 and $90 — implies a meaningful, roughly 32% advance from the recent price near $64. The case for reaching it rests on record revenue, a growing backlog, defense-sector demand, and an exceptionally clean balance sheet. The case against it rests on a premium valuation, margin pressure, thin and cautious sell-side coverage, and the stock's demonstrated tendency to overshoot in both directions. With only two Hold-rated analysts and a target that sits between the current price and a prior high, MPTI's path toward $85 depends more on sustained execution and backlog conversion than on any single catalyst. No outcome is assured, and the target is a reference point, not a prediction.
In my own work tracking names like this, I find Tickeron’s AI Daily Buy/Sell Signals helpful for spotting shifts in momentum on volatile small-caps. The platform uses AI to scan thousands of stocks and generate signals based on technicals and market conditions, which serves as a practical complement to reviewing analyst notes and fundamentals without replacing deeper research.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for MPTI moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In 15 of the 17 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 42 cases where MPTI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +6.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where MPTI advanced for three days, in 193 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
MPTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MPTI as a result. In 53 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for MPTI turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 28 similar instances when the indicator turned negative. In 20 of the 28 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
The 50-day moving average for MPTI moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MPTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for MPTI entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.209) is normal, around the industry mean (3.856). P/E Ratio (20.845) is within average values for comparable stocks, (6.228). Projected Growth (PEG Ratio) (1.170) is also within normal values, averaging (0.930). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. P/S Ratio (4.968) is also within normal values, averaging (4.422).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. MPTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MPTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ElectronicComponents